These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9413101)

  • 21. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccination against respiratory syncytial virus in young calves.
    Taylor G; Bruce C; Barbet AF; Wyld SG; Thomas LH
    Vaccine; 2005 Jan; 23(10):1242-50. PubMed ID: 15652666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
    Ellis JA; Gow SP; Goji N
    J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of priming for bovine respiratory syncytial virus-specific protective immune responses following parenteral vaccination of passively immune calves.
    Ellis J; Gow S; Bolton M; Burdett W; Nordstrom S
    Can Vet J; 2014 Dec; 55(12):1180-5. PubMed ID: 25477547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments.
    Mars MH; de Jong MC; van Oirschot JT
    Vaccine; 2000 Apr; 18(19):1975-81. PubMed ID: 10706958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves.
    Hägglund S; Hu K; Vargmar K; Poré L; Olofson AS; Blodörn K; Anderson J; Ahooghalandari P; Pringle J; Taylor G; Valarcher JF
    Vaccine; 2011 Nov; 29(47):8719-30. PubMed ID: 21864616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of DNA application methods to reduce BRSV shedding in cattle.
    Schrijver RS; Langedijk JP; Keil GM; Middel WG; Maris-Veldhuis M; Van Oirschot JT; Rijsewijk FA
    Vaccine; 1998; 16(2-3):130-4. PubMed ID: 9607020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses to bovine respiratory syncytial virus (BRSV) following use of an inactivated BRSV-PI3-Mannheimia haemolytica vaccine and a modified live BRSV-BVDV vaccine.
    Kerkhofs P; Tignon M; Petry H; Mawhinney I; Sustronck B
    Vet J; 2004 Mar; 167(2):208-10. PubMed ID: 14975397
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA vaccination against pseudorabies virus and bovine respiratory syncytial virus infections of young animals in the face of maternally derived immunity.
    Hamers C; Juillard V; Fischer L
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S35-41. PubMed ID: 17553517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves.
    Woolums AR; Brown CC; Brown JC; Cole DJ; Scott MA; Williams SM; Miao C
    Am J Vet Res; 2004 Mar; 65(3):363-72. PubMed ID: 15027687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Priming of multiple T cell subsets by modified-live and inactivated bovine respiratory syncytial virus vaccines.
    Sandbulte MR; Roth JA
    Vet Immunol Immunopathol; 2003 Oct; 95(3-4):123-33. PubMed ID: 12963273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical status and endoscopy of the upper respiratory tract of dairy calves infected with Bovine viral diarrhea virus 2 and Bovine herpes virus 1 after vaccination and trace minerals injection.
    Hoyos-Jaramillo A; Palomares RA; Bittar JH; Divers SJ; Chamorro MF; Berghaus R; Kirks SJ; Rush J; Edmondson M; Rodriguez A; Gonzalez-Altamiranda EA
    Res Vet Sci; 2022 Dec; 152():582-595. PubMed ID: 36201905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
    Ellis JA; Gow SP; Mahan S; Leyh R
    J Am Vet Med Assoc; 2013 Dec; 243(11):1602-8. PubMed ID: 24261811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal booster vaccination of beef steers reduces clinical signs following experimental coinfection with BRSV and BHV-1 without reducing shedding of BRD-associated bacteria.
    Martínez DA; Chamorro MF; Passler T; Huber L; Falkenberg S; Walz PH; Thoresen M; Raithel G; Silvis S; Dimitrov KM; Stockler R; Woolums AR
    Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38422620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine.
    Kleiboeker SB; Lee SM; Jones CA; Estes DM
    J Am Vet Med Assoc; 2003 May; 222(10):1399-403. PubMed ID: 12762386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling of local disease-sparing responses to bovine respiratory syncytial virus in intranasally vaccinated and challenged calves.
    Gray D; Ellis JA; Gow SP; Lacoste SR; Allan GM; Mooney MH
    J Proteomics; 2019 Jul; 204():103397. PubMed ID: 31146050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
    Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
    Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.